title: Is it justified to exclude patients with minor stroke from intravenous thrombolysis?
authors.forename: Jorge
authors.initials: J
authors.lastname: García-García
authors.forename: Oscar
authors.initials: O
authors.lastname: Ayo-Martín
authors.forename: Tomas
authors.initials: T
authors.lastname: Segura
mesh_terms: D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D018579:Patient Selection; D011994:Recombinant Proteins / Q000008:administration & dosage; D012720:Severity of Illness Index; D013064:Speech Disorders / Q000209:etiology*; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator